Customize your JAMA Network experience by selecting one or more topics from the list below.
The Original Investigation titled “Azithromycin for Acute Exacerbations of Asthma: The AZALEA Randomized Clinical Trial,”1 published in the November 2016 issue of JAMA Internal Medicine, reported incorrect numbers of adverse events owing to a recently discovered error in the AZALEA clinical trial database. In the last paragraph of the Results section, “a reduced frequency of respiratory, thoracic, and mediastinal (63 of 64 respiratory) adverse events (27 vs 37, respectively)” should read “a reduced frequency of respiratory, thoracic, and mediastinal (61 of 62 respiratory) adverse events (26 vs 36, respectively).” In the online-only Supplement, numbers of adverse events were reported incorrectly in eTables 16 through 19. This article and its supplement have been corrected online.
Incorrect Numbers of Adverse Events Reported. JAMA Intern Med. 2018;178(7):1003. doi:10.1001/jamainternmed.2018.2967